Application of L-threonine transaldolase to synthesis of florfenicol chiral intermediates
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 福建昌生生物科技发展有限公司
- Publication Date
- 2019-12-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of biotechnology and chemical engineering, and in particular relates to the application of L-threonine transaldolase in the synthesis of florfenicol chiral intermediates. Background technique
[0002] (2S,3R)-P-thymphenylphenylserine is the key chiral building block for the synthesis of Florfenicol. Florfenicol is a β-aminoalcohol antibiotic. It has the advantages of rapid absorption, wide distribution in the body, long half-life, no aplastic anemia side effects, no drug resistance, no residue, and no cross-resistance. It is an alternative to chloramphenicol. and thiamphenicol, a new generation of chloramphenicol antibiotics. It is mainly used to treat bacterial diseases and mycoplasma infections in pigs, chickens and fish caused by sensitive bacteria, and has unique curative effects on diseases caused by Escherichia coli in livestock and poultry, porcine infectious pleuropneumonia and panting disease. In recent ye...